Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
A Study of Alisertib in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Recurrent or Metastatic Breast Cancer
Apply
Alisertib & Endocrine Therapy
A Study of Alisertib in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Recurrent or Metastatic Breast Cancer
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step